Rifampin 1 ug/mL

Understand what Rifampin 1 ug/mL signals

Primary unit: ug/ml
LOINC codes: 107337-8, 12-5, 16100-0, 16623-1, 185-9, 189-1, 225-3, 29254-0, 31037-5, 335-0, 428-3, 42803-7, 460-6, 29576-6, 516-5, 29579-0, 11502-2, 4021-2, 4428-9, 45285-4, 20461-0, 25194-2, 25202-3, 25205-6, 25218-9, 25219-7, 31208-2, 8251-1
Commercial laboratory assays: 9

We have not added a physiological summary for this biomarker yet. Compare the commercial laboratory assays and population reference ranges below.

Compare commercial laboratory assays for Rifampin 1 ug/mL

Check orderable catalog codes, specimen types, fasting requirements, and demographic reference ranges across laboratories.

Mycobacterium avium Complex MIC Panel

Laboratory: Quest Diagnostics
Test code: 19796
Specimen: 1 slant/plate/broth pure culture of isolate safely contained in Lowenstein-Jensen or Middlebrook 7H10 agar slant/plate or equivalent or positive AFB broth medium isolate safely contained in a double-walled container
Fasting: Not stated
LOINC: 107337-8, 12-5, 16100-0, 16623-1, 185-9, 189-1, 225-3, 29254-0, 31037-5, 335-0, 428-3, 42803-7, 460-6
Turnaround: Set up: Mon-Fri

Laboratory assay overview

Mycobacterium avium and other slow-growing mycobacteria cause a variety of human infections. Antimicrobial susceptibility testing may be an aid for treatment options.

View complete laboratory reference notes

See Laboratory Report

Quest Diagnostics test directory, test code 19796

Mycobacterium avium Complex Susceptibility−Broth Dilution

Laboratory: Labcorp
Test code: 182832
Specimen: Mycobacterium avium complex isolated from a primary clinical specimen
Fasting: Not stated
LOINC: 29576-6
Turnaround: 21 - 30 days

Laboratory assay overview

Determine the susceptibility of Mycobacterium avium complex isolates to a profile of antimycobacterial agents. Testing is recommended for isolates from patients with previous macrolide therapy, patients who relapse while on macrolide therapy, or patients with initial isolates from blood, tissue, or clinically relevant respiratory specimens. Repeat susceptibility is recommended after 3 months (disseminated disease) or 6 months (chronic pulmonary disease) if the cultures are still positive or if there is no clinical improvement. First line drugs for M. avium complex treatment includes clarithromycin and amikacin (IV or inhaled). Clarithromycin is the most appropriate class drug for the macrolides due to technical challenges with azithromycin. Second line drugs include moxifloxacin and linezolid, however, the in vivo effectiveness of these drugs for treatment of M. avium complex is unproven. These are the only drugs with CLSI interpretations for M. avium complex. Note that while ethambutol can be used as part of the treatment regimen for M. avium complex, studies have shown that MIC values do not correlate with clinical outcomes. For this reason, ethambutol is not reported for M. avium complex isolates.

Labcorp test directory, test code 182832

Mycobacterium marinum Susceptibility (AST)−Broth Dilution

Laboratory: Labcorp
Test code: 182840
Specimen: Mycobacterium marinum isolate from a primary clinical specimen should be submitted on conventional solid or broth AFB broth medium.
Fasting: Not stated
LOINC: 29576-6
Turnaround: 21 - 28 days

Laboratory assay overview

Determine the susceptibility of Mycobacterium marinum isolates to relevant antimycobacterial agents. Routine susceptibility testing of M. marinum isolates is generally not recommended.1,2 The following agents are typically found to be susceptible when testing M. marinum: Rifampin, Ethambutol, Doxycycline, Minocycline, Clarithromycin and Trimethoprim-sulfamethoxazole.3 Disease due to M. marinum is generally localized and the number of organisms is low, with 95% of tissue biopsies reported as AFB smear negative. Susceptibility testing should be considered when patients remain culture positive after several months of therapy.4

Labcorp test directory, test code 182840

Mycobacterium Slow Grower MIC

Laboratory: Quest Diagnostics
Test code: 19775
Specimen: 1 slant
Fasting: Not stated
LOINC: 12-5, 16100-0, 16623-1, 185-9, 189-1, 225-3, 29254-0, 31037-5, 335-0, 428-3, 42803-7, 460-6, 516-5
Turnaround: Set up: Mon-Fri; Report available: 28-35 days

Laboratory assay overview

Mycobacterium avium and other slow-growing mycobacteria cause a variety of human infections. Antimicrobial susceptibility testing may be an aid for treatment options.

Quest Diagnostics test directory, test code 19775

Mycobacterium tuberculosis Susceptibility, Broth Dilution and Confirmation

Laboratory: Labcorp
Test code: 182576
Specimen: Swab
Fasting: Not stated
Turnaround: 30 - 40 days

Laboratory assay overview

Determine the susceptibility of Mycobacterium tuberculosis to a profile of antimycobacterial agents.

Labcorp test directory, test code 182576

Nontuberculous Slowly-growing Mycobacterium Susceptibility−Broth Dilution

Laboratory: Labcorp
Test code: 182923
Specimen: Slowly-growing mycobacteria
Fasting: Not stated
LOINC: 29579-0
Turnaround: 35 - 40 days

Laboratory assay overview

Determine the susceptibility of nontuberculous slowly-growing mycobacterial isolates to a profile of antimycobacterial agents. Clinical breakpoints for M. kansasii and Nontuberculosis Mycobacteria other than M. avium Complex are the same. Some fastidious isolates may not exhibit adequate growth for susceptibility testing ( M. genvense, M. haemophilum ). Others such as M. gordonae are rarely clinically relevant and susceptibility testing is not recommended. If patients are not responding to several months of therapy, repeat susceptibility testing is recommended.

Labcorp test directory, test code 182923

Rifampin Level

Laboratory: Quest Diagnostics
Test code: 92017
Specimen: Serum
Fasting: Not stated
LOINC: 11502-2, 4021-2, 4428-9, 45285-4
Turnaround: Set up: Mon-Fri

View complete laboratory reference notes

See Laboratory Report

Quest Diagnostics test directory, test code 92017

Rifampin, Serum or Plasma

Laboratory: Labcorp
Test code: 809675
Specimen: Serum
Fasting: Not stated
Turnaround: 10 - 14 days

Laboratory assay overview

Therapeutic drug management

View complete laboratory reference notes

The effective concentration range of rifampin is dependent on the minimum inhibitory concentration (MIC) for the pathogen being treated.

Labcorp test directory, test code 809675

Susceptibility, Mycobacterium tuberculosis

Laboratory: Quest Diagnostics
Test code: 7950
Specimen: Pure isolate collected on an agar slant or MGIT tube in a double-walled container
Fasting: Not stated
LOINC: 20461-0, 25194-2, 25202-3, 25205-6, 25218-9, 25219-7, 31208-2, 42803-7, 8251-1
Turnaround: Set up: 3x per week, as needed

Laboratory assay overview

Susceptibility reports can be used as a guide in the choice of first course therapy or in confirming antimicrobial resistance that leads to a further course of treatment. Also used to estimate the prevalence of primary and acquired antimicrobial resistance in a community.

View complete laboratory reference notes

See Laboratory Report

Quest Diagnostics test directory, test code 7950

Verify these ranges and sources

We compile every detail above directly from named laboratory directories and published clinical studies. Laboratories calculate standard reference intervals from the statistical distribution of tested populations for a specific assay method and demographic group, rather than setting universal optimal targets.

Always review your personal lab results with a licensed clinician, or track your lab history and health goals in Aumnivida.

Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.